This is ludicrous. Hey steady on out there. Anyone would think that the company's whole future was hanging on BTD for Rett's. [No, the people who have been hurt by this decision are the sufferer's and their families, whose hopeful waiting for some relief and symptomatic turn-a-round is going to be extended.] We are not a one trick pony. There are 3 ongoing Phase II trials, all with at least some good reasons to anticipate success, and none of which are in any way whatsoever impacted by this result. Nor, is the ultimate efficacy (or not) of 'trof' in Rett's.
Get a grip - the SP will recover. I am out of my current disappointment and more into this one.
SP over-reaction
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.626B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $5.431M | 266.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1475 | $22.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.47 | 2461 | 2 |
View Market Depth
| Last trade - 15.59pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |